TY - JOUR
T1 - Design and analytical validation of clinical DNA sequencing assays
AU - Pont-Kingdon, Genevieve
AU - Gedge, Friederike
AU - Wooderchak-Donahue, Whitney
AU - Schrijver, Iris
AU - Weck, Karen E.
AU - Kant, Jeffrey A.
AU - Oglesbee, Devin
AU - Bayrak-Toydemir, Pinar
AU - Lyon, Elaine
PY - 2012/1
Y1 - 2012/1
N2 - Context.-DNA sequencing is the method of choice for mutation detection in many genes. Objectives.-To demonstrate the analytical accuracy and reliability of DNA sequencing assays developed in clinical laboratories. Only general guidelines exist for the validation of these tests. We provide examples of assay validation strategies for DNA sequencing tests. Design.-We discuss important design and validation considerations. Results.-The validation examples include an accuracy study to evaluate concordance between results obtained by the newly designed assay and analyzed by another method or laboratory. Precision (reproducibility) studies are performed to determine the robustness of the assay. To assess the quality of sequencing assays, several sequence quality measures are available. In addition, assessing the ability of primers to specifically and robustly amplify target regions before sequencing is important. Conclusion.-Protocols for validation of laboratorydeveloped sequencing assays may vary between laboratories. An example summary of a validation is provided.
AB - Context.-DNA sequencing is the method of choice for mutation detection in many genes. Objectives.-To demonstrate the analytical accuracy and reliability of DNA sequencing assays developed in clinical laboratories. Only general guidelines exist for the validation of these tests. We provide examples of assay validation strategies for DNA sequencing tests. Design.-We discuss important design and validation considerations. Results.-The validation examples include an accuracy study to evaluate concordance between results obtained by the newly designed assay and analyzed by another method or laboratory. Precision (reproducibility) studies are performed to determine the robustness of the assay. To assess the quality of sequencing assays, several sequence quality measures are available. In addition, assessing the ability of primers to specifically and robustly amplify target regions before sequencing is important. Conclusion.-Protocols for validation of laboratorydeveloped sequencing assays may vary between laboratories. An example summary of a validation is provided.
UR - http://www.scopus.com/inward/record.url?scp=84856035237&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84856035237&partnerID=8YFLogxK
U2 - 10.5858/arpa.2010-0623-OA
DO - 10.5858/arpa.2010-0623-OA
M3 - Article
C2 - 22208486
AN - SCOPUS:84856035237
SN - 0003-9985
VL - 136
SP - 41
EP - 46
JO - Archives of Pathology and Laboratory Medicine
JF - Archives of Pathology and Laboratory Medicine
IS - 1
ER -